FTSE 100 down 0.8%, FTSE 250 flat AstraZeneca drops after lung cancer drug trial setback Centamin soars after AngloGold Shanti's buyout offer UK pay growth cools to more than two-year low IQE ...

(RTTNews) - AstraZeneca (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) datopotamab deruxtecan (Dato-DXd) did not significantly improve overall survival for adult patients with locally advanced or ...

WILMINGTON, Del. - AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) has shown a trend toward improving overall survival (OS) compared with chemotherapy in a Phase ...

Paul Tunnah sat down with AstraZeneca's vice president of sustainability strategy and engagement Jim Massey to discuss how the global pharma company is embracing a green future. There has been a ...

Over the weekend, the U.S. government announced first-ever negotiated prices for prescription drugs for ten drugs covered ...

Carillon Eagle Growth & Income Fund highlighted stocks like AstraZeneca PLC (NASDAQ:AZN) in the second quarter 2024 investor letter. AstraZeneca PLC (NASDAQ:AZN) is a biopharmaceutical company ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the other 52-week high stocks. The U.S. stock market has been on a roll, with major indices ...

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that add up to a wide moat. The strong replenishment of new drugs ...

Qiagen and AstraZeneca are expanding their diagnostics partnership, with plans to explore the use of genomic profiling in chronic diseases beyond cancer. The long-time collaborators, which ...

Qiagen said Wednesday it has expanded its collaboration with AstraZeneca to cover companion diagnostics for chronic diseases. The agreement, which moves the partnership beyond oncology, tasks Qiagen ...